Product
CV0701
Aliases
CV0701 Bivalent High dose, CV0701 Bivalent Low dose, CV0701 Bivalent Medium dose
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 2 Randomized, Active-controlled, Observer-blind Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Booster Dose of Investigational COVID-19 mRNA Vaccines in Healthy Adults Who Previously Received a Complete Primary Vaccination Series With or Without Booster Dose(s)Status: Active (not recruiting), Estimated PCD: 2024-08-28